Scientific Sessions 2024  /  Evaluating Long-Term Outcomes and Real-World Impact of Cardiac Myosin Inhibition in Adults with Symptomatic NYHA Class II-III Obstructive HCM  /  Long-Term and Real-World Outcomes for Cardiac Myosin Inhibition in Adults With Symptomatic NYHA Class II–III Obstructive HCM
Logo

American Heart Association

  2
  0

Final ID:

Long-Term and Real-World Outcomes for Cardiac Myosin Inhibition in Adults With Symptomatic NYHA Class II–III Obstructive HCM

  • Harper, Mariko  ( Virginia Mason , Seattle , Washington , United States )
    • Author Disclosures:
    mariko harper: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Evaluating Long-Term Outcomes and Real-World Impact of Cardiac Myosin Inhibition in Adults with Symptomatic NYHA Class II-III Obstructive HCM

Sunday, 11/17/2024 , 11:15AM - 12:00PM

Heart Theater

More abstracts from these authors:
Navigating the Complexities of Hypertrophic Cardiomyopathy (HCM): Addressing Delayed Diagnosis, Disease Burden, and Shared Decision-Making

Halbmaier Katie, Harper Mariko

You have to be authorized to contact abstract author. Please, Login
Not Available